Chronic fatigue has dozens of possible causes, ranging from treatable conditions like thyroid disorders and anemia to the more complex and poorly understood myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The distinction matters: chronic fatigue is a symptom that can stem from many sources, while ME/CFS is a specific disease affecting roughly 1.09 million adults in the United States alone, with prevalence expected to rise following the COVID-19 pandemic.
Common Conditions That Cause Chronic Fatigue
Before considering ME/CFS, it’s worth knowing that persistent, draining fatigue is a feature of many medical conditions. Sleep apnea is one of the most frequently overlooked culprits. People with undiagnosed obstructive sleep apnea wake feeling unrefreshed no matter how many hours they sleep, which closely mimics ME/CFS. Thyroid dysfunction, particularly an underactive thyroid, slows metabolism and leaves you feeling heavy and exhausted. Iron-deficiency anemia reduces the oxygen-carrying capacity of your blood, producing fatigue that worsens with physical effort.
Depression and anxiety disorders also produce fatigue, sleep disturbances, and cognitive fog that can look nearly identical to ME/CFS. Autoimmune conditions like lupus, rheumatoid arthritis, and fibromyalgia share similar overlapping symptoms. Lyme disease, multiple sclerosis, chronic respiratory diseases like COPD, and even some neurological conditions such as early Parkinson’s disease can all present with persistent fatigue as a primary complaint. This is why getting a thorough medical workup matters. Many of these conditions are treatable, and resolving the underlying problem often resolves the fatigue.
What Makes ME/CFS Different
ME/CFS isn’t simply being tired all the time. The diagnostic criteria established in 2015 require three core symptoms plus at least one additional feature. First, there must be a substantial drop in your ability to function at work, school, or in daily life that lasts longer than six months, accompanied by fatigue that is new (not lifelong), not caused by excessive exertion, and not meaningfully relieved by rest.
Second, you must experience post-exertional malaise, or PEM: a worsening of symptoms after physical, mental, or emotional effort that previously wouldn’t have been a problem. Third, sleep must be unrefreshing, meaning a full night of rest doesn’t leave you feeling recovered. On top of these three, a diagnosis requires either cognitive impairment (problems with memory, attention, and processing speed) or orthostatic intolerance (symptoms that worsen when you stand upright). These symptoms need to occur at least half the time at moderate or greater severity.
The disease affects three times as many women as men. Most people develop it between the ages of 20 and 45, though it can appear in adolescents as well. Prevalence in high-income countries ranges from 0.2% to 1% of the population.
Viral Infections as a Trigger
Many cases of ME/CFS begin after a viral infection. Epstein-Barr virus (the virus behind mono) and influenza have long been associated with post-viral fatigue that, in some people, never fully resolves. COVID-19 has brought fresh attention to this pattern, as a subset of long COVID patients meet the full diagnostic criteria for ME/CFS.
The current thinking follows a “two-hit model.” The first hit, typically an infection or toxic exposure, creates a state of vulnerability in the body. The second hit, which can be something as ordinary as exercise or stress, ignites the cycle of symptoms. In healthy people, the body bounces back from these stressors. In ME/CFS, the recovery system appears to be fundamentally broken.
Cells That Can’t Produce Enough Energy
One of the most consistent findings in ME/CFS research is that cells struggle to produce energy normally. Healthy cells generate energy through a process called oxidative phosphorylation, which takes place inside mitochondria. In ME/CFS patients, this process is impaired. Studies using specialized imaging of skeletal muscles during exercise have found lower rates of energy (ATP) production and increased acidity inside cells, suggesting the body is relying more heavily on a less efficient backup energy system called glycolysis.
Research from the National Institutes of Health has identified a specific protein, encoded by a gene called WASF3, that appears to be overproduced in ME/CFS patients. When levels of this protein rise, it physically disrupts the energy-producing machinery inside mitochondria. Muscle biopsies from ME/CFS patients showed elevated levels of this protein along with clear signs of cellular stress and reduced components of the energy production chain, compared to healthy volunteers. The protein also promotes a shift toward glycolysis, further suppressing normal mitochondrial energy output.
This energy deficit also increases oxidative stress, a condition where damaging molecules called reactive oxygen species accumulate faster than the body can neutralize them. ME/CFS patients show elevated markers of this damage in their blood, including signs of damaged fats, proteins, and DNA, alongside lower levels of protective antioxidants like coenzyme Q10.
Why Exercise Makes It Worse
Post-exertional malaise is the hallmark symptom that separates ME/CFS from ordinary fatigue, and its biology is becoming clearer. In a healthy person, moderate exercise creates a small burst of oxidative stress that the body uses as a signal to build stronger defenses and grow new mitochondria. It’s a productive kind of stress. In ME/CFS, the body has lost this adaptive capacity. The same level of exertion triggers inflammatory cascades and oxidative damage instead of repair.
During exertion, already-impaired mitochondria produce even more reactive oxygen species, which leak from the energy production chain. These molecules don’t just damage cells directly. They also act as alarm signals that activate the immune system. Damaged mitochondria release fragments of their own DNA, which immune cells recognize as a threat, firing up inflammatory pathways that were designed to fight infections. The muscle weakness people feel during a crash may not simply be from running out of energy. It likely involves damage to the ion pumps that maintain electrical signaling in muscle cells, caused by the combination of oxidative stress, inadequate energy supply, and disrupted hormonal signaling.
An Immune System Stuck in Overdrive
The immune picture in ME/CFS is paradoxical. Standard blood tests for inflammation, like C-reactive protein and sedimentation rate, typically come back normal. But more detailed analysis reveals a different story. A study published in the Proceedings of the National Academy of Sciences found that while only two immune signaling molecules differed between patients and healthy controls overall, 17 of these molecules correlated with disease severity. Thirteen of those were pro-inflammatory, meaning the sicker the patient, the more active the inflammatory response.
Patients also show increased numbers of activated immune cells circulating in their blood. Daily fluctuations in the inflammatory hormone leptin have been linked to day-to-day changes in fatigue severity. This creates a frustrating diagnostic gap: patients feel profoundly ill, but their routine lab work looks unremarkable. The inflammation is real, but it operates through channels that standard tests don’t measure.
Inflammation Inside the Brain
Brain imaging studies suggest ME/CFS involves a state of chronic, low-grade neuroinflammation. This isn’t the kind of brain inflammation you’d see in meningitis or a stroke. It’s subtler but widespread. Whole-brain scanning has revealed elevated temperatures in multiple brain regions, including areas involved in body awareness, movement, sensory processing, and the relay of information between brain regions. Higher brain temperatures are a marker of local inflammatory activity.
These same scans found elevated lactate levels across many brain regions. Lactate at high levels in the brain is abnormal and is produced by immune cells under inflammatory conditions. Markers of accelerated cell membrane breakdown were elevated in areas responsible for attention and emotional regulation. Together, these findings point to immune cells in the brain (called microglia) being stuck in an activated, pro-inflammatory state, which would directly explain the cognitive fog, difficulty concentrating, and impaired memory that ME/CFS patients describe.
The peripheral immune activation feeds this cycle. Inflammatory molecules from the rest of the body cross into the brain through dedicated transport systems. When systemic inflammation is sustained, as it is in ME/CFS, these molecules can also degrade the barrier that normally protects the brain, allowing even more inflammatory signals through.
Gut Bacteria and the Immune Connection
ME/CFS patients consistently show altered gut bacteria compared to healthy people. Several research teams have found reduced populations of beneficial, anti-inflammatory bacteria and increases in potentially harmful ones. Specifically, patients tend to have lower levels of bacteria that produce butyrate, a short-chain fatty acid that feeds the gut lining and keeps it intact. They also show increases in certain bacterial species that have been identified as potential diagnostic markers for the condition.
The consequences extend far beyond digestion. About two-thirds of ME/CFS patients in one study showed elevated blood markers indicating that bacterial components were leaking through the gut wall into the bloodstream. This “leaky gut” triggers immune activation and systemic inflammation. Bacterial toxins that escape the gut may also damage the gut lining further, creating a self-reinforcing loop: inflammation damages the gut barrier, more bacterial products leak through, and more inflammation follows. Researchers have speculated that toxic byproducts of this process, including certain fats released when bacterial toxins are broken down, may directly harm gut cells and worsen permeability over time.
Hormonal Disruption
The stress hormone system, specifically the loop connecting the brain’s hypothalamus, the pituitary gland, and the adrenal glands, functions abnormally in a high proportion of ME/CFS patients. The most common pattern is hypocortisolism: cortisol levels that are chronically lower than normal. Patients also show a flattened daily cortisol rhythm (the normal peak in the morning and trough at night is blunted) and an exaggerated negative feedback response, meaning the system over-corrects and suppresses cortisol production too aggressively.
Cortisol plays a central role in regulating energy, immune function, and the body’s response to stress. Chronically low cortisol could explain why the immune system remains overactive (cortisol normally acts as a brake on inflammation) and why patients feel unable to mount an appropriate response to everyday physical and mental demands. Changes in the molecular machinery that reads cortisol-related genes have been found in patients, offering one possible explanation for why cortisol levels run low despite the body being under obvious stress.
How These Systems Feed Each Other
What makes ME/CFS so difficult to treat is that none of these problems exist in isolation. Mitochondrial dysfunction produces oxidative stress, which activates the immune system. Immune activation drives neuroinflammation, which disrupts hormonal regulation. Hormonal disruption removes the brakes on inflammation. Gut permeability adds fuel to immune activation. Each broken system worsens the others, creating a self-sustaining cycle that the body cannot resolve on its own. This is likely why the disease persists for years and why no single intervention has proven broadly effective: correcting one piece of the puzzle doesn’t stop the other pieces from driving the process forward.